Effects of Crestor on inflammation of atherosclerotic plaques

Study identifier:D4411M00010

ClinicalTrials.gov identifier:N/A

EudraCT identifier:N/A

CTIS identifier:N/A

Study Complete

Official Title

Exploratory study of new imaging biomarkers for measurement of carotid plaque inflammation

Medical condition

Atherosclerosis

Phase

N/A

Healthy volunteers

Yes

Study drug

rosuvastatin, placebo

Sex

All

Actual Enrollment

74

Study type

Interventional

Age

18 Years - 70 Years

Date

Study Start Date: 01 Dec 2007
Primary Completion Date: -
Study Completion Date: 01 Jun 2009

Study design

Allocation: Randomized
Endpoint Classification: N/A
Intervention Model: Parallel Assignment
Masking: Double Blind
Primary Purpose: Basic Science

Verification:

Verified 01 Nov 2013 by AstraZeneca Pharmaceuticals

Sponsors

AstraZeneca Pharmaceuticals

Collaborators

-

Inclusion and exclusion criteria